Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and Tissues
- 1 March 1986
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 9 (4) , 845-859
- https://doi.org/10.1080/01483918608076673
Abstract
A procedure for the analysis of blood and tissue specimens for WR1065, the dephosphorylated metabolite of the radioprotective drug WR2721, has been developed. The method includes the use of a perchloric acid/EDTA extraction step at 0°C followed by chromatographic analysis using a mercury/gold thin film electrochemical detection liquid chromatography system. The extraction technique was designed to assure the stability of both WR1065 and any WR2721 present in blood or tissues. Using the described chromatography conditions and an analog of WR1065, 3-(4-aminopropylamino)propanethiol (WR251833), as an internal standard the respective retention times of these two compounds are 6.2 and 8.3 minutes. Experiments showing the applicability of this method to pharmacokinetic studies of WR2721 and WR1065 and to investigation of the kinetics of WR2721 hydrolysis in biological fluids such as stomach juice are described.This publication has 14 references indexed in Scilit:
- A Liquid Chromatographic Electrochemical Assay for S-2-(3-Aminopropylamino) Ethylphosphorothioate (WR2721) in Human PlasmaJournal of Liquid Chromatography, 1984
- Phase I trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Phase I Controlled trials of WR-2721 and cyclophosphamideInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Toxicity of WR-2721 administered in single and multiple dosesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- HPLC assay for 2-(3-aminopropylamino)ethanethiol (WR-1065) in plasmaInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983
- Liquid Chromatographic Behavior of Biological Thiols and the Corresponding DisulfidesJournal of Liquid Chromatography, 1983
- HPLC Assay forS-2-(3-Aminopropylamino)ethyl Phosphorothioate (WR 2721) in PlasmaJournal of Liquid Chromatography, 1983
- Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamideBritish Journal of Cancer, 1980